Your browser doesn't support javascript.
loading
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Mohan, Hema; Friese, Anita; Albrecht, Stefanie; Krumbholz, Markus; Elliott, Christina L; Arthur, Ariel; Menon, Ramesh; Farina, Cinthia; Junker, Andreas; Stadelmann, Christine; Barnett, Susan C; Huitinga, Inge; Wekerle, Hartmut; Hohlfeld, Reinhard; Lassmann, Hans; Kuhlmann, Tanja; Linington, Chris; Meinl, Edgar.
Afiliação
  • Mohan H; Institute of Clinical Neuroimmunology, Ludwig Maximilian University Munich, Marchioninistraße 15, D-81377, Munich, Germany. hema.mohan@ukmuenster.de.
  • Friese A; Present address: Department of Neurology, University of Münster, Münster, Germany. hema.mohan@ukmuenster.de.
  • Albrecht S; Institute of Clinical Neuroimmunology, Ludwig Maximilian University Munich, Marchioninistraße 15, D-81377, Munich, Germany. anita.friese@web.de.
  • Krumbholz M; Institute of Neuropathology, University Hospital Münster, Münster, Germany. stefanie.albrecht@ukmuenster.de.
  • Elliott CL; Institute of Clinical Neuroimmunology, Ludwig Maximilian University Munich, Marchioninistraße 15, D-81377, Munich, Germany. markus.krumbholz@med.uni-muenchen.de.
  • Arthur A; Division of Clinical Neurosciences, University of Glasgow, Glasgow, UK. Christina.Elliott@glasgow.ac.uk.
  • Menon R; Division of Clinical Neurosciences, University of Glasgow, Glasgow, UK. ariel.arthur@gmail.com.
  • Farina C; Division of Neuroscience, Institute of Experimental Neurology (INSpe), San Raffaele Scientific Institute, Milan, Italy. menon.ramesh@hsr.it.
  • Junker A; Division of Neuroscience, Institute of Experimental Neurology (INSpe), San Raffaele Scientific Institute, Milan, Italy. farina.cinthia@hsr.it.
  • Stadelmann C; Institute for Neuropathology, Göttingen, Germany. andreas.junker@med.uni-goettingen.de.
  • Barnett SC; Institute for Neuropathology, Göttingen, Germany. cstadelmann@med.uni-goettingen.de.
  • Huitinga I; Division of Clinical Neurosciences, University of Glasgow, Glasgow, UK. Susan.Barnett@glasgow.ac.uk.
  • Wekerle H; The Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, Netherlands. i.huitinga@nin.knaw.nl.
  • Hohlfeld R; Max Planck Institute of Neurobiology, Hertie Senior Professorship, Martinsried, Germany. Hartmut.Wekerle@med.uni-muenchen.de.
  • Lassmann H; Institute of Clinical Neuroimmunology, Ludwig Maximilian University Munich, Marchioninistraße 15, D-81377, Munich, Germany. Reinhard.Hohlfeld@med.uni-muenchen.de.
  • Kuhlmann T; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Reinhard.Hohlfeld@med.uni-muenchen.de.
  • Linington C; Center for Brain Research, Medical University of Vienna, Vienna, Austria. hans.lassmann@meduniwien.ac.at.
  • Meinl E; Institute of Neuropathology, University Hospital Münster, Münster, Germany. Tanja.Kuhlmann@ukmuenster.de.
Acta Neuropathol Commun ; 2: 168, 2014 Dec 11.
Article em En | MEDLINE | ID: mdl-25589163
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Espinal / Encéfalo / Fator 1 de Crescimento de Fibroblastos / Esclerose Múltipla / Bainha de Mielina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Espinal / Encéfalo / Fator 1 de Crescimento de Fibroblastos / Esclerose Múltipla / Bainha de Mielina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article